TRACON Pharmaceuticals, Inc. (TCON)

NASDAQ: TCON · IEX Real-Time Price · USD

2.110

-0.180 (-7.86%)

At close: Apr 18, 2024, 4:00 PM

2.090

-0.020 (-0.95%)

Pre-market: Apr 19, 2024, 4:10 AM EDT

TRACON Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	12.05	0	0.35	0	0	3	8.76	3.45	7.9	3.6	Upgrade
Revenue Growth (YoY)	-	-	-	-	-	-65.73%	153.84%	-56.36%	119.68%	-	Upgrade
Gross Profit	12.05	0	0.35	0	0	3	8.76	3.45	7.9	3.6	Upgrade
Selling, General & Admin	6.67	14.01	17.55	8.03	7.77	7.28	7.61	7.86	5.69	2.13	Upgrade
Research & Development	12.28	13.89	11.15	8.2	14.53	30.46	19.36	21.57	25.68	7.65	Upgrade
Other Operating Expenses	2.38	0	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	21.32	27.89	28.69	16.22	22.3	37.74	26.97	29.43	31.37	9.78	Upgrade
Operating Income	-9.27	-27.89	-28.35	-16.22	-22.3	-34.74	-18.21	-25.98	-23.47	-6.18	Upgrade
Interest Expense / Income	7.3	0.99	0.32	0.55	0.39	0.23	0.89	1.12	0.92	0.67	Upgrade
Other Expense / Income	-12.99	0.25	0	0.01	-0.01	-0.01	0.01	-0.09	0.02	-0.04	Upgrade
Pretax Income	-3.59	-29.14	-28.67	-16.78	-22.67	-34.96	-19.1	-27.01	-24.41	-6.81	Upgrade
Net Income	-3.59	-29.14	-28.67	-16.78	-22.67	-34.96	-19.1	-27.01	-24.41	-6.81	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	0	0.03	0.3	Upgrade
Net Income Common	-3.59	-29.14	-28.67	-16.78	-22.67	-34.96	-19.1	-27.01	-24.44	-7.11	Upgrade
Shares Outstanding (Basic)	2	1	1	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	2	1	1	0	0	0	0	0	0	0	Upgrade
Shares Change	56.53%	21.25%	92.03%	196.09%	12.61%	60.33%	32.57%	14.06%	588.27%	0.01%	Upgrade
EPS (Basic)	-2.20	-27.80	-33.20	-37.40	-149.40	-259.40	-227.40	-426.00	-440.00	-880.00	Upgrade
EPS (Diluted)	-2.20	-27.80	-33.20	-37.40	-149.40	-259.40	-227.40	-426.00	-440.00	-880.00	Upgrade
Free Cash Flow	3.68	-26.26	-22.62	-17.05	-23.65	-30.78	-13.28	-27.15	-19.29	1.69	Upgrade
Free Cash Flow Per Share	2.25	-25.10	-26.22	-37.95	-155.88	-228.48	-158.06	-428.35	-347.08	209.03	Upgrade
Gross Margin	100.00%	-	100.00%	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-76.99%	-	-8192.77%	-	-	-1158.00%	-208.00%	-753.15%	-296.90%	-171.73%	Upgrade
Profit Margin	-29.79%	-	-8285.26%	-	-	-1165.30%	-218.20%	-783.07%	-309.22%	-197.50%	Upgrade
Free Cash Flow Margin	30.52%	-	-6537.28%	-	-	-1026.10%	-151.71%	-787.27%	-244.05%	46.91%	Upgrade
EBITDA	3.75	-28.07	-28.41	-16.24	-22.27	-34.7	-18.17	-25.8	-23.44	-6.13	Upgrade
EBITDA Margin	31.13%	-	-8210.40%	-	-	-1156.67%	-207.53%	-747.90%	-296.51%	-170.29%	Upgrade
Depreciation & Amortization	0.03	0.07	-0.06	-0.01	0.02	0.03	0.05	0.09	0.05	0.02	Upgrade
EBIT	3.72	-28.14	-28.35	-16.23	-22.29	-34.73	-18.22	-25.89	-23.49	-6.14	Upgrade
EBIT Margin	30.85%	-	-8193.35%	-	-	-1157.60%	-208.08%	-750.62%	-297.15%	-170.71%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).